By Lisa Mascaro
The House Ethics Committee announced Thursday it is launching an investigation into embattled Republican Rep. George Santos, the New York congressman whose lies and embellishments about his resume and personal life have drawn deep scrutiny in Congress.
The bipartisan leaders of the committee announced the panel had voted unanimously to establish an investigative subcommittee to look into the allegations. The panel voted to take action on Tuesday.
The investigation appears to be far reaching. It seeks to determine “whether Representative George Santos may have: engaged in unlawful activity with respect to his 2022 congressional campaign” among other actions, the committee said in a statement.
The probe will review whether Santos "failed to properly disclose required information on statements filed with the House, violated federal conflict of interest laws in connection with his role in a firm providing fiduciary services, and/or engaged in sexual misconduct towards an individual seeking employment in his congressional office," the statement said.
Panel leaders — Republican Rep. David Joyce of Ohio and Democratic Rep. Susan Wild of Pennsylvania — will lead the probe, with two other lawmakers from each party.
Santos had already removed himself from his committee assignments but otherwise has refused calls from Republicans in New York to step down from office.
"The Committee notes that the mere fact of establishing an Investigative Subcommittee does not itself indicate that any violation has occurred," the statement said.
A new poll finds most U.S. adults are worried about health care becoming more expensive.
The White House budget office says mass firings of federal workers have started in an attempt to exert more pressure on Democratic lawmakers as the government shutdown continues.
President Donald Trump says “there seems to be no reason” to meet with Chinese leader Xi Jinping as part of an upcoming trip to South Korea after China restricted exports of rare earths needed for American industry. The Republican president suggested Friday he was looking at a “massive increase” of import taxes on Chinese products in response to Xi’s moves. Trump says one of the policies the U.S. is calculating is "a massive increase of Tariffs on Chinese products coming into the United States." A monthslong calm on Wall Street was shattered, with U.S. stocks falling on the news. The Chinese Embassy in Washington hasn't responded to an Associated Press request for comment.
Most members of the Federal Reserve’s interest-rate setting committee supported further reductions to its key interest rate this year, minutes from last month’s meeting showed.
From Wall Street trading floors to the Federal Reserve to economists sipping coffee in their home offices, the first Friday morning of the month typically brings a quiet hush around 8:30 a.m. eastern, as everyone awaits the Labor Department’s monthly jobs report.
The Supreme Court is allowing Lisa Cook to remain as a Federal Reserve governor for now.
Rep. John Moolenaar has requested an urgent briefing from the White House after Trump supported a deal giving Americans a majority stake in TikTok.
A new report finds the Department of Government Efficiency’s remaking of the federal workforce has battered the Washington job market and put more households in the metropolitan area in financial distress.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
